Nuropod is now available in North America, offering a wearable vagus nerve stimulation device designed to support the body's natural calming response without medication.

Sacramento, United States, September 22, 2026 /PressCable/ -- As per a recent company announcement, Nuropod is now available in North America, providing consumers with a wearable vagus nerve stimulation device designed to support relaxation and the body's natural calming response through non-invasive neuromodulation. Developed for everyday wellness, the device offers a research-backed option for people looking to support nervous system health as part of their daily routine.

More information is available at https://nuropod.com/

The announcement comes as more people look for non-pharmaceutical approaches that complement healthy lifestyle habits and support relaxation. Designed to support the body's natural calming response, and supported by research from the Journal of Physiology and other publications, non-invasive vagus nerve stimulation devices are increasingly being incorporated into daily wellness routines by people seeking to feel less mentally and physically overloaded over time.

Nuropod works by clipping a small wearable earpiece onto the tragus, the part of the outer ear just in front of the ear canal where the vagus nerve reaches the skin. Using Parasym's proprietary AVNT™ approach, the device delivers gentle electrical stimulation to support that natural system. "The goal is to work with the body's own calming mechanisms through comfortable, everyday use," a company spokesperson said.

Many people incorporate Nuropod into quiet moments that already fit naturally into their day, such as reading, unwinding after work, or during meditation, adds the representative. Most users wear the device for around 30 minutes once or twice a day while continuing with their usual activities, allowing nervous system wellness to become part of an established routine.

Nuropod is supported by more than 10 years of vagus nerve stimulation research connected to Parasym, including over 60 peer-reviewed scientific studies, more than 150 research collaborations, and over five million neuromodulation sessions. In clinical studies, anxious thoughts fell by an average of 35%. Research has also reported improvements in vagus nerve activity, heart rate variability, and relaxation-related nervous system markers. "Our focus has always been to make research-backed neuromodulation practical for everyday wellness," the Nuropod spokesperson added.

Those interested can find additional information by visiting https://nuropod.com/blogs/articles/best-vagus-nerve-stimulation-device-for-anxiety

Disclaimer: Research referenced in this article was conducted using Parasym's neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-designated risk device and is not intended to diagnose, treat, cure, or prevent any disease.

Contact Info:
Name: Victor Kho
Email: Send Email
Organization: Nuropod
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/

Source: PressCable

Release ID: 89204015

In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.